| K-ras oncogene subtype mutations are associated with survival but not expression of p53, p16(INK4A), p21(WAF-1), cyclin D1, erbB-2 and erbB-3 in resected pancreatic ductal adenocarcinoma. | pancreatic, |
| [CCND1 oncogene amplification and cellular DNA content in squamous cell carcinomas of the head and neck]. | HNSC, |
| Polymorphisms in cyclin D1 gene and hepatocellular carcinoma. | liver, |
| Cyclin D1 is a candidate oncogene in cutaneous melanoma. | skin, |
| Cyclin D1 is a candidate oncogene in cutaneous melanoma. | skin, |
| The cyclin D1 gene is overexpressed in human breast cancers and is required for oncogene-induced tumorigenesis | breast, |
| Array-based comparative genomic hybridization analysis identified cyclin D1 as a target oncogene at 11q13.3 in nasopharyngeal carcinoma. | nasopharyngeal,laryngeal, |
| Expression of constitutively nuclear cyclin D1 in murine lymphocytes induces B-cell lymphoma. | lymphoma, |
| p16, retinoblastoma (pRb), and cyclin D1 protein expression in human endometriotic and adenomyotic lesions. | retinoblastoma, |
| PRAD1, a candidate BCL1 oncogene: mapping and expression in centrocytic lymphoma. | lymphoma, |
| HER2, TOP2A, CCND1, EGFR and C-MYC oncogene amplification in colorectal cancer. | colorectal, |
| Tissue-specific consequences of cyclin D1 overexpression in prostate cancer progression. | prostate, |
| The etiology of gastric cancer is involved in multiple genetic and epigenetic alterations, by molecular biological study, including oncogenes cell-cycle regulators (such as cyclin D1) | gastric, |
| Study on the different expression of molecular markers between cardiac cancer and distal gastric cancer and their correlations with clinicopathological features. | gastric, |
| The water extract of the lettuce Lactuca sativa activated checkpoint kinase 2, induced the tumour suppressor p21, and downregulated the proto-oncogene cyclin D1 in HL-60 leukaemia cells and MCF-7 breast cancer cells | breast, |
| Down-regulation of the oncogene cyclin D1 increases migratory capacity in breast cancer and is linked to unfavorable prognostic features. | breast, |
| Expression of cyclin D1 proto-oncogene mRNA in primary meningiomas may contribute to tumorigenesis. | meningiomas, |
| Cinacalcet HCl suppresses Cyclin D1 oncogene-derived parathyroid cell proliferation in a murine model for primary hyperparathyroidism. | thyroid, |
| CCND1 G870A polymorphism modulated oncogenic cyclin D1b expression in glioma tissues and may be associated with an increased risk of gliomas in Chinese population | glioma, |
| Oncogene abnormalities in a series of primary melanomas of the sinonasal tract: NRAS mutations and cyclin D1 amplification are more frequent than KIT or BRAF mutations. | skin, |